Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLOPIDOGREL BISULFATE USP, with a corresponding US DMF Number 26890.
Remarkably, this DMF maintains an Active status since its submission on March 04, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 18, 2013, and payment made on May 14, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II